Pembrolizumab In Central Nervous System Metastases

NCT02886585 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

101

Enrollment

OTHER

Sponsor class

Conditions

Brain Metastases

Interventions

DRUG: Pembrolizumab
RADIATION: MRI
RADIATION: PET/CT
PROCEDURE: Stereotactic Radiosurgery

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]